Literature DB >> 26421864

Osteonecrosis of the jaw a new complication related to Ipilimumab.

Adepitan A Owosho1, Michael Scordo2, SaeHee K Yom3, Joseph Randazzo3, Paul B Chapman4, Joseph M Huryn3, Cherry L Estilo5.   

Abstract

Entities:  

Keywords:  Ipilimumab; Melanoma; Osteonecrosis of the jaw

Mesh：

Substances：

Year:  2015        PMID： 26421864      PMCID： PMC4784100          DOI： 10.1016/j.oraloncology.2015.08.014

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  11 in total

Review 1.  Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.

Authors:  Grazia Graziani; Lucio Tentori; Pierluigi Navarra
Journal:  Pharmacol Res       Date:  2011-09-10       Impact factor: 7.658

2.  CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.

Authors:  Peter A Prieto; James C Yang; Richard M Sherry; Marybeth S Hughes; Udai S Kammula; Donald E White; Catherine L Levy; Steven A Rosenberg; Giao Q Phan
Journal:  Clin Cancer Res       Date:  2012-01-23       Impact factor: 12.531

3.  Osteonecrosis of the jaw related to bevacizumab.

Authors:  Cherry L Estilo; Monica Fornier; Azeez Farooki; Diane Carlson; George Bohle; Joseph M Huryn
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

4.  Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.

Authors:  Vittorio Fusco; Claudia Galassi; Alfredo Berruti; Libero Ciuffreda; Cinzia Ortega; Giovannino Ciccone; Alberto Angeli; Oscar Bertetto
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

5.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

6.  Osteonecrosis of the jaw in a patient on Denosumab.

Authors:  Tara L Aghaloo; Alan L Felsenfeld; Sotirios Tetradis
Journal:  J Oral Maxillofac Surg       Date:  2010-02-10       Impact factor: 1.895

7.  Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Authors:  Robert E Marx; Yoh Sawatari; Michel Fortin; Vishtasb Broumand
Journal:  J Oral Maxillofac Surg       Date:  2005-11       Impact factor: 1.895

8.  Sunitinib related osteonecrosis of jaw: a case report.

Authors:  Yoram Fleissig; Eran Regev; Hadas Lehman
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-01-02

9.  Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.

Authors:  Cherry L Estilo; Catherine H Van Poznak; Tijaana Wiliams; George C Bohle; Phyu T Lwin; Qin Zhou; Elyn R Riedel; Diane L Carlson; Heiko Schoder; Azeez Farooki; Monica Fornier; Jerry L Halpern; Steven J Tunick; Joseph M Huryn
Journal:  Oncologist       Date:  2008-08-11

10.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136
View more
  11 in total

1.  Osteonecrosis of the jaw associated with ziv-aflibercept.

Authors:  Hani Mawardi; Peter Enzinger; Nadine McCleary; Reshma Manon; Alessandro Villa; Nathaniel Treister; Sook-Bin Woo
Journal:  J Gastrointest Oncol       Date:  2016-12

Review 2.  [Progress on medication-related osteonecrosis of the jaw].

Authors:  Qi-Zhang Wang; Ji-Yuan Liu; Jian Pan
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-10-01

3.  Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report.

Authors:  Xerxes Pundole; Amy Little Jones; Michael T Tetzlaff; Michelle D Williams; William A Murphy; Adegbenga Otun; Ryan P Goepfert; Michael A Davies
Journal:  Immunotherapy       Date:  2020-09-09       Impact factor: 4.196

4.  Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.

Authors:  Adepitan A Owosho; Ariel Blanchard; Lauren Levi; Arvin Kadempour; Haley Rosenberg; SaeHee K Yom; Azeez Farooki; Monica Fornier; Joseph M Huryn; Cherry L Estilo
Journal:  J Craniomaxillofac Surg       Date:  2015-12-20       Impact factor: 2.078

5.  Immune-Related Oral, Otologic, and Ocular Adverse Events.

Authors:  Nagham Al-Zubidi; J Cody Page; Dan S Gombos; Akanksha Srivastava; Eric Appelbaum; Paul W Gidley; Mark S Chambers; Marc-Elie Nader
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.

Authors:  Ourania Nicolatou-Galitis; Maria Kouri; Erofili Papadopoulou; Emmanouil Vardas; Dimitra Galiti; Joel B Epstein; Sharon Elad; Giuseppina Campisi; Nikolaos Tsoukalas; Kivanc Bektas-Kayhan; Winston Tan; Jean-Jacques Body; Cesar Migliorati; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2018-10-23       Impact factor: 3.603

Review 7.  Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology.

Authors:  Antonio Fabrizio Nifosì; Mariateresa Zuccarello; Lorenzo Nifosì; Vanessa Hervas Saus; Gianfilippo Nifosì
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2019-02-26

8.  New-generation anticancer drugs and medication-related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy.

Authors:  Agostino Guida; Francesco Perri; Franco Ionna; Paolo A Ascierto; Antonio M Grimaldi
Journal:  Clin Case Rep       Date:  2020-12-02

Review 9.  Review and update on drugs related to the development of osteonecrosis of the jaw.

Authors:  A Eguia; L Bagán-Debón; F Cardona
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01

Review 10.  Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.

Authors:  Minerva Codruta Badescu; Elena Rezus; Manuela Ciocoiu; Oana Viola Badulescu; Lacramioara Ionela Butnariu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.